The proteasome in brain aging

Ageing Research Reviews

Volumn 1, Issue 2, 2002, Pages 279-293

  Keller, Jeffrey N ^a,b   Gee, Jillian ^a   Ding, Qunxing ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Central nervous system; Oxidative stress; Proteasome; Protein oxidation

Indexed keywords

ALPHA SYNUCLEIN; ANTIOXIDANT; APOLIPOPROTEIN; CASPASE; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN RECEPTOR ALPHA; HISTONE; INOSITOL TRISPHOSPHATE; INTERLEUKIN RECEPTOR; LIPOFUSCIN; MYELIN BASIC PROTEIN; OPIATE RECEPTOR; PARKIN; PRESENILIN 1; PROTEASOME; PROTEIN DERIVATIVE; PROTEIN P53; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX;

AGING; BRAIN MATURATION; CATALYSIS; CATALYST; CELL DEATH; CENTRAL NERVOUS SYSTEM; CORRELATION ANALYSIS; CYTOLOGY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE DEGENERATION; OXIDATION; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN TARGETING; REVIEW; BRAIN; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

AGING; BRAIN; CYSTEINE ENDOPEPTIDASES; HUMANS; MULTIENZYME COMPLEXES; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0036546011     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(01)00006-X     Document Type: Review

References (83)

1. Agarwal S., Sohal R.S. Aging and proteolysis of oxidized proteins. Arch. Biochem. Biophys. 309:1996;24-28.
2. Akaishi T., Shiomi T., Sawada H., Yokosawa H. Purification and properties of the 26S proteasome from the rat brain: evidence for its degradation of myelin basic protein in a ubiquitin-dependent manner. Brain Res. 722:1996;139-144.
3. Alkalay I., Yaron A., Hatzubai A., Orian A., Ciechanover A., Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 92:1995;10599-10603.
4. Anselmi B., Conconi M., Veyrat-Durebex C., Turlin E., Biville F., Alliot J., Friguet B. Dietary self-selection can compensate an age-related decrease of rat liver 20 S proteasome activity observed with standard diet. J. Gerontol. A Biol. Sci. Med. Sci. 53:1998;B173-B179.
5. Benaroudj N., Tarcsa E., Cascio P., Goldberg A.L. The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie. 8:2001;311-318.
6. Brown M.G., Monaco J.J. Biochemical purification of distinct proteasome subsets. Enzyme Protein. 47:1993;343-353.
7. Bulteau A.L., Petropoulos I., Friguet B. Age-related alterations of proteasome structure and function in aging epidermis. Exp. Gerontol. 35:2000;767-777.
8. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. USA. 88:1991;3633-3636.
9. Chain D.G., Hedge A.N., Yamamoto N., Liu-Marsh B., Schwartz J.H. Persistent activation of camp dependent protein kinase by regulated proteolysis suggests a neuron-specific function of the ubiquitin system in Aplysia. J. Neurosci. 15:1995;7592-7603.
10. Chaturvedi K., Bandari P., Chinen N., Howells R.D. Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors. J. Biol. Chem. 276:2001;12345-12355.
11. Chen Z., Hagler J., Palombella V.J., Melandri F., Scerer D., Ballard D., Maniatas T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1995;1586-1597.
12. Choi P., Ostrerova-Golts N., Sparkman D., Cochran E., Lee J.M., Wolozin B. Parkin is metabolized by the ubiquitin/proteasome system. NeuroReport. 11:2000;2635-2638.
13. Chondrogianni N., Petropoulos I., Franceschi C., Friguet B., Gonos E.S. Fibroblast cultures from healthy centenarians have an active proteasome. Exp. Gerontol. 35:2000;721-728.
14. Conconi M., Szweda L.I., Levine R.L., Stadtman E.R., Friguet B. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch. Biochem. Biophys. 331:1996;232-240.
15. Davies K.J. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 83:2001;301-310.
16. DeMartino G.N., Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274:1999;22123-22126.
17. Deshaies R.J., Chau V., Kirchner M. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J. 14:1995;303-312.
18. Ding Q., Keller J.N. Proteasomes and proteasome inhibition in the central nervous system. Free Radic. Biol. Med. 31:2001a;574-584.
19. Ding Q., Keller J.N. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J. Neurochem. 77:2001b;1010-1017.
20. Forster M.J., Sohal B.H., Sohal R.S. Reversible effects of long-term caloric restriction on protein oxidative damage. J. Gerontol. A Biol. Sci. Med. Sci. 55:2000;B522-B529.
21. Friguet B. Dietary self-selection can compensate an age-related decrease of rat liver 20S proteasome activity observed with standard diet. J. Gerontol. A Biol. Med. Sci. 53:1998;B179-B179.
22. Friguet B., Szweda L.I. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 405:1997;21-25.
23. Fruh K., Gossen M., Wang K., Bujard H., Peterson P.A., Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteanase complex. EMBO J. 13:1994;3236-3244.
24. Glockzin S., von Knethen A., Scheffner M., Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274:1999;19581-19586.
25. Glotzer M., Murray A.W., Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature. 349:1991;132-138.
26. Goldberg A.L., Akopain T.N., Kisselev A.F., Lee D.H., Rohrwild M. New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol. Chem. 378:1997;131-140.
27. Grune T., Reinheckel T., Davies K.J.A. Degradation of oxidized proteins in mammalian cells. FASEB J. 11:1997;526-534.
28. Grune T., Blasig I.E., Sitte N., Roloff B., Haseloff R., Davies K.J. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J. Biol. Chem. 273:1998;10857-10862.
29. Harries J.R. Release of a macromolecular protein component from human erythrocyte ghost. Biochem. Biophys. Acta. 150:1968;534-537.
30. Honda T., Yasutake K., Nihonmatsu N., Mercken M., Takahashi H., Murayama O., Murayama M., Sato K., Omori A., Tsubuki S., Saido T.C., Takashima A. Dual roles of proteasome in the metabolism of presenilin 1. J. Neurochem. 72:1999;255-261.
31. Ingano L.A., Lentini K.M., Kovacs I., Tanzi R.E., Kovacs D.M. Cytoplasmic presenilin aggregates in proteasome inhibitor-treated cells. Ann. NY Acad. Sci. 920:2000;259-260.
32. Johnston J.A., Ward C.L., Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell. Biol. 143:1998;1883-1898.
33. Keller J.N., Markesbery W.R. Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death. J. Neurosci. Res. 61:2000;436-442.
34. Keller J.N., Hanni K.B., Markesbery W.R. Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 113:2000a;61-70.
35. Keller J.N., Huang F.F., Markesbery W.R. Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience. 98:2000b;149-156.
36. Keller J.N., Huang F.F., Zhu J., Yu J., Ho Y.S., Kindy M.S. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 20:2000c;1467-1473.
37. Keller J.N., Huang F.F., Dimayuga E.R., Maragos W.F. Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic. Biol. Med. 29:2000d;1037-1042.
38. Lonard D.M., Nawaz Z., Smith C.L., O'Malley B.W. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell. 5:2000;939-948.
39. Lopes U.G., Erhardt E., Yao R., Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272:1997;12893-12896.
40. Luders J., Demand J., Hohfeld J. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J. Biol. Chem. 275:2000;4613-4617.
41. Marambaud P., Lopez-Perez E., Wilk S., Checler F. Constitutive and protein kinase C-regulated secretory cleavage of Alzheimer's beta-amyloid precursor protein: different control of early and late events by the proteasome. J. Neurochem. 69:1997;2500-2505.
42. Massa S.M., Swanson R.A., Sharp F.R. The stress gene response in brain. Cerebrovasc. Brain Metab. Rev. 8:1996;95-158.
43. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107:2001;247-254.
44. McLean P.J., Kawamata H., Hyman B.T. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience. 104:2001;901-912.
45. Mengual L., Arizti P., Rodrigo J., Gimenez-Amaya J.M., Castano J.G. Immunohistochemical distribution and electron microscopic subcellular localization of the proteasome in the rat CNS. J. Neurosci. 16:1996;6331-6341.
46. Merker K., Sitte N., Grune T. Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts. Arch. Biochem. Biophys. 375:2000;50-54.
47. Merker K., Stolzing A., Grune T. Proteolysis, caloric restriction, and aging. Mech. Ageing Dev. 122:2001;595-615.
48. Mo X.Y., Cascio P., Lemerise K., Goldberg A.L., Rock K. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J. Immunol. 163:1999;5851-5859.
49. Noda C., Tanahashi N., Shimbara N., Hendil K.B., Tanaka K. Tissue distribution of constituative proteasomes, immunoproteasomes, and PA28 in rats. Biochem. Biophys. Res. Commun. 277:2000;348-354.
50. Oberdorf J., Webster J.M., Zhu C.C., Luo S.G., Wojcikiewicz R.J. Down-regulation of types I, II, and III inositol 1,4,5-triphophate receptors is mediated by the ubiquitin/proteasome pathway. Biochem. J. 339:1999;453-461.
51. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 274:1999;23787-23793.
52. Pacifici R.E., Salo D.C., Davies K.J. Macroproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic. Biol. Med. 7:1989;521-536.
53. Pasquini L.A., Besio-Moreno M., Adamo A.M., Pasquini J.M., Soto E.F. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59:2000;601-611.
54. Petropoulos I., Conconi M., Wang X., Hoenel B., Bregegere F., Milner Y., Friguet B. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J. Gerontol. A Biol. Sci. Med. Sci. 55:2000;B220-B227.
55. Qui J.H., Asai A., Chi S., Saito N., Hamada H., Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20:2000;259-265.
56. Rodriguez M.S., Desterro J.M., Lain S., Lane D.P., Hay R.T. Multiple C- terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell Biol. 20:2000;8458-8467.
57. Salmena L., Lam V., McPherson J.P., Goldenberg G.J. Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase II alpha expression. Biochem. Pharmacol. 61:2001;795-802.
58. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
59. Skovronsky D.M., Pijak D.S., Doms R.W., Lee V.M. A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP. Biochemistry. 39:2000;810-817.
60. Reinheckel T., Sitte N., Ullrich O., Knuckelkorn U., Davies K.J., Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 335:1998;637-642.
61. Rivett J.A. Purification of a liver alkaline protease which degrades oxidatively modified glutamine synthetase: characterization as a high molecular weight cytseine protease. J. Biol. Chem. 260:1985;12600-12606.
62. Rivett A.J. Proteasomes: multicatalytic proteinase complexes. Biochem. J. 291:1993;1-10.
63. Russell S.J., Reed S.H., Huang W., Friedberg E.C., Johnston S.A. The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol. Cell. 3:1999;687-695.
64. Sahakian J.A., Szweda L.I., Friguet B., Kitani K., Levine R.L. Aging of the liver: proteolysis of oxidatively modified glutamine synthetase. Arch. Biochem. Biophys. 318:1995;411-417.
65. Saka N., Stoops J.D., Dixon J.L. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotien B in permeabilized HepG2 cells. J. Biol. Chem. 274:1999;17068-17074.
66. Shringarpure R., Grune T., Sitte N., Davies K.J. 4-Hydroxynonenal- modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell. Mol. Life Sci. 57:2000;1802-1809.
67. Sitte N., Merker K., Von Zglinicki T., Grune T. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic. Biol. Med. 28:2000a;701-708.
68. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Zglinicki T., Davies K.J. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14:2000b;1490-1498.
69. Sitte N., Merker K., Von Zglincki T., Grune T., Davies K.J. Protein oxidation and degradation during cellular senescence of human BJ fibroblast: part I - effects of proliferative senescence. FASEB J. 14:2000c;2495-2502.
70. Sitte N., Merker K., Von Zglinicki T., Davies K.J., Grune T. Protein oxidation and degradation during cellular senescence of human BJ fibroblast: part II - aging of nondividing cells. FASEB J. 14:2000d;2503-2510.
71. Stadtman E.R. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9:1990;315-325.
72. Stohwasser R., Giesebrecht J., Kraft R., Muller E.C., Hausler K.G., Kettenmann H., Hanisch U.K., Kloetzel P.M. Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide. Glia. 29:2000;355-365.
73. Stohwasser R., Kloetzel P.M. Cytokine induced changes in proteasome subunit composition are concentration dependent. Biol. Chem. 377:1996;571-577.
74. Strack P.R., Waxman L., Fagan J.M. Activation of the multicatalytic endopeptidase by oxidants. Effects on enzyme structure. Biochemistry. 35:1996;7142-7149.
75. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hendil K.B., Tanaka K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP- dependent proteolysis. J. Biol. Chem. 275:2000;14336-14345.
76. Tanaka K. Proteasomes: structure and biology. J. Biochem. (Tokyo). 123:1998;195-204.
77. Tanaka K., Chiba T. The proteasome: a protein-destroying machine. Genes Cells. 3:1998;499-510.
78. Tanaka Y., Engelender S., Igarashi S., Rao R.K., Wanner T., Tanzi R.E., Sawa A., Dawson L., Dawson T.M., Ross C.A. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10:2001;919-926.
79. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., Davies K.J. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA. 96:1999;6223-6228.
80. Voges D., Zwickl P., Baumeister W. The 26S proteasome: a machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1999;1015-1068.
81. Wilk S., Orlowski M. Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme. J. Neurochem. 35:1980;1172-1182.
82. Yen C.H., Yang Y.C., Ruscetti S.K., Kirken R.A., Dai R.M., Li C.C. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoiten. J. Immunol. 165:2000;6372-6380.
83. Yenari M.A., Giffard R.G., Sapolsky R.M., Steinberg G.K. The neuroprotective potential of heat shock protein 70 (HSP70). Mol. Med. Today. 5:1999;525-531.